Skip to main content

Table 2 National cancer and death registrations versus outcomes review confirmation of tubo-ovarian cancer (a) diagnosis and (b) cause of death

From: Completeness and accuracy of national cancer and death registration for outcome ascertainment in trials—an ovarian cancer exemplar

Registry assigned Outcomes review confirmed (reference standard) Totals
Tubo-ovariana cancer (ICD-10 C56 /C57.0) Malignant neoplasm of unknown origin (C80) No cancer Other primary cancer
a. Diagnosis (primary cancer site)
Ovarian/tubal or primary peritoneal cancer (ICD-10 C56 /C57/C48) 1125 33 26 48b 1232
Malignant neoplasm of unknown origin (C80) 9 91 7 48 155
Benign and ovarian neoplasms of uncertain behaviour (ICD-10 D39.1) 36 0 25 4 65
Other primary cancers 2 2 0 18 22
Total with registry and outcomes review 1172 126 58 118 1474
b. Cause of death
Ovarian/tubal or primary peritoneal cancer (ICD-10 C56 /C57/C48) 605 26 6 19c 656
Malignant neoplasm of unknown origin (C80) 27 272 10 117 426
Benign and ovarian neoplasms of uncertain behaviour (ICD-10 D39.1) 2 0 4 0 6
Other primary cancer 11 58 2 882 953
Total 645 356 22 1018 2041
  1. aWHO 2014, includes cancers previously classified as primary peritoneal cancer
  2. bendometrium 20; leiomyosarcoma broad ligament 4; cervix 1; appendix 3; cecum 1; small bowel 2; bile duct 1; breast 2; colon 5; GI stromal 1; lung 1; NHL 3; pancreas 1; skin 1; small lymphocytic lymphoma 1; vulva 1
  3. cendometrium (10), colon (3), and one each due to breast cancer, peritoneal mesothelioma, kidney cancer, T cell non-Hodgkin’s lymphoma, lung cancer and oral squamous cell carcinoma